ENDV
ENDONOVO THERAPEUTICS, INC.$0.00010000 +0.00 (+0.00%)
Oct 26 4:00 PM ET · prev $0.00010000
1 year
0.0%
from $0.00010000 · Oct 27
30 days
+100.0%
from $0.00005000
52-week range
$0.00005000–0.000200
−50% from high · low Jan 27
Avg volume 20D
67.6K
Sep 30 spike 650.0K
Price
Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.
No data for this timeframe.
- E Jul 13 Trial readout: Results Pending: EN3835 (Phase 3) — Completed 34d ago
- E Jul 17 Trial readout: Results Pending: EN3835 (Phase 3) — Completed 38d ago
- E Jul 21 Trial readout: Results Pending: EN3835 (Phase 3) — Completed 42d ago
- E Aug 10 Trial readout: Results Pending: EN3835 (Phase 3) — Completed 62d ago
- E Aug 11 Trial readout: Results Pending: EN3835 (Phase 3) — Completed 63d ago
- E Aug 25 Trial readout: Results Pending: EN3835 (Phase 3) — Completed 77d ago
Signal stack
Where each data set points today.
- TrendUPTREND
23% above its 50-day average. New closing low $0.00005000 on Oct 20.
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Aug 25, 2026 Clinical trial readout
Results Pending: EN3835 (Phase 3) — Completed 77d ago
Trial: Study to Assess EN3835 in the Treatment of Plantar Fibromatosis (Also Known as Ledderhose Dis
Jul 28, 2026 Event
PERCOCET
WARNING: SERIOUS AND LIFE-THREATENING RISKS FROM USE OF PERCOCET Addiction, Abuse, and Misuse Becaus
Earnings setup
Estimates| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | — | — | — | $0.00 |
| Next Q | — | — | — | $0.00 |
| Current FY | — | — | — | $0.00 |
| Next FY | — | — | — | $0.00 |
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent
Aug 25, 2026
Trial readout
Results Pending: EN3835 (Phase 3) — Completed 77d ago
Trial: Study to Assess EN3835 in the Treatment of Plantar Fibromatosis (Also Known as Ledderhose Disease) Sponsor: Endo USA Inc., a Keenova…
Aug 11, 2026
Trial readout
Results Pending: EN3835 (Phase 3) — Completed 63d ago
Trial: Study to Assess EN3835 in the Treatment of Plantar Fibromatosis (Also Known as Ledderhose Disease) Sponsor: Endo USA Inc., a Keenova…
Aug 10, 2026
Trial readout
Results Pending: EN3835 (Phase 3) — Completed 62d ago
Trial: Study to Assess EN3835 in the Treatment of Plantar Fibromatosis (Also Known as Ledderhose Disease) Sponsor: Endo USA Inc., a Keenova…
Jul 28, 2026
FDA
PERCOCET
WARNING: SERIOUS AND LIFE-THREATENING RISKS FROM USE OF PERCOCET Addiction, Abuse, and Misuse Because the use of PERCOCET exposes patients and other u
Jul 21, 2026
Trial readout
Results Pending: EN3835 (Phase 3) — Completed 42d ago
Trial: Study to Assess EN3835 in the Treatment of Plantar Fibromatosis (Also Known as Ledderhose Disease) Sponsor: Endo USA Inc., a Keenova…